Delivery Order SPE2DB22D3009-SPE2DB25FAW12

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,042.97 firm-fixed-price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device, with a period of performance through April 29, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQETD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,495.86 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a period of performance through April 30, 2025. Amerisourcebergen Drug Corp also holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,881.39 firm-fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device used in the treatment of diabetes. The contract has a period of performance through May 15, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This federal contract award, with ID SPE2DB24D2217|SPE2DB25FJWUH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S. The firm-fixed-price delivery order has a ceiling value of $1,392.44 and an ultimate completion date of April 22, 2025. The contract is not set aside and is considered an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.52 firm-fixed-price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The contract has an ultimate completion date of March 26, 2025 and was awarded on March 25, 2025. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen also...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,580.56 firm fixed-price delivery order is for the procurement of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,267.60 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device, with a period of performance through April 30, 2025. This award is not associated with a set-aside program and is likely part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices to the Defense Logistics Agency (DLA), a defense agency. The $1,816.31 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 16, 2025, with a completion date of May 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,460.68 firm-fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The contract has an ultimate completion date of March 5, 2025 and was awarded on March 4, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $3,706.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of March 18, 2025. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB22D3009
    Indefinite Delivery Contract
  • SPE2DB22D3009-SPE2DB25FAW12
    Delivery Order

This federal contract award, identified as SPE2DB22D3009|SPE2DB25FAW12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,134.26 firm fixed-price delivery order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices, with a performance period through April 29, 2025.

Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/28/25, 11:05 AM